Galectin-3 expression is induced in cirrhotic liver and hepatocellular carcinoma

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 519-526

  Hsu, Daniel K ^a   Dowling, Christopher A ^b   Jeng, K C George ^c   Chen, Jung Ta ^c   Yang, Ri Yao ^a   Liu, Fu Tong ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 3;

ARTICLE; CANCER INVASION; HEPATITIS B; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR GROWTH;

ANIMALS; ANTIGENS, DIFFERENTIATION; BIOPSY; CARCINOMA, HEPATOCELLULAR; GALECTIN 3; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B; HEPATITIS B ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LECTINS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICE; ORGAN SPECIFICITY; PROMOTER REGIONS (GENETICS); SPLEEN; THYMUS GLAND; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0032963712     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.0.CO;2-0     Document Type: Article

References (39)

1. ADEN, D.P., FOGEL, A., PLOTKIN, S., DAMJAMOV, I. and KNOWLES, B.B., Controlled systhesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature (Lond.), 282, 615-616 (1979).
2. AKAHANI, S., NANGIA-MAKKER, P., INOHARA, H., KIM, H.R.C. and RAZ, A., Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res., 57, 5272-5276 (1997).
3. ALEXANDER, J., BEY, E., WHITCUTT, M. and GEAR, J., Adaptation of cells derived from human malignant tumors to growth in vitro. S. Afr. J. med. Sci., 41, 89-98 (1976).
4. BARONDES, S.H., COOPER, D.N.W., GITT, M.A. and LEFFLER, H., Galectins: structure and function of a large family of animal lectins. J. biol. Chem., 269, 20807-20810 (1994).
5. BERMAN, M.M., LIBBEY, N.P. and FOSTER, J.H., Hepatocellular carcinoma. Polygonal cell type with fibrous stroma: an atypical variant with a favorable prognosis. Cancer, 46, 1448-1455 (1980).
6. CASTRONOVO, V., CAMPO, E., VANDEN BRÚLE, F.A., CLAYSMITH, A.P., CIOCE, V., LIU, F.T., FERNANDEZ, D.L. and SOBEL, M.E., Inverse modulation of steady state mRNA levels of two non-integrin laminin binding proteins in human colon carcinoma. J. nat. Cancer Inst., 84, 1161-1167 (1992).
7. CASTRONOVO, V., VAN DEN BRÚLE, F.A., JACKERS, P., CLAUSSE, NIU, F.T, GILLET, C. SOBEL, M.E., Decreased expression of galectin-3 is associated with progression of human breast cancer. J. Pathol., 179, 43-48 (1996).
8. CHISARI, F.V., Analysis of hepadnavirus gene expression, biology, and pathogenesis in the transgenic mouse. In Current topics in microbiology and immunology, pp. 85-99, Springer, Berlin (1991).
9. CRAIG, J.R., PETERS, R.L., EDMONDSON, H.A. and OMATA, M., Fibrolamellar carcinoma of the liver: A tumor of adolescents and young adults with distinctive clinico-pathologic features. Cancer, 46, 372-379 (1980).
10. CRITTENDEN, S.L., ROFF, C.F. and WANG, J.L., Carbohydrate-binding protein 35: identification of the galactose-specific lectin in various tissues of mice. Mol. Cell Biol., 4, 1252-1259 (1984).
11. DAGHER, S.F., WANG, J.L. and PATTERSON, R.J., Identification of galectin-3 as a factor in pre-mRNA splicing. Proc. nat. Acad. Sci (Wash.), 92, 1213-1217 (1995).
12. FAUSTO, N. and THOMPSON, N.L., Purification and culture of oval cells from rat liver. In T.G. Pretlow II and T.P. Pretlow (eds.), Cell Separation: Methods and selected applications, pp. 45-96, Academic Press, Orlando (1986).
13. FLOTTE, T.J., SPRINGER, T.A. and THORBECKE, G.J., Dendritic cell and macrophage staining by monoclonal antibodies in tissue sections and epidermal sheets. Amer. J. Pathol., 111, 112-124 (1983).
14. GERBER, M.A., THUNG, S.N., SHEN, S., STROMEYER, F.W. and ISHAK, K.G., Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver. Amer. J. Pathol., 110, 70-74 (1983).
15. HSU, D.K., HAMMES, S.R., KUWABARA, I., GREENE, W.C. and LIU, F.-T. Human T lymphotropic virus-1 infection of human T lymphocytes induces expression of the β-galactose-binding lectin, galectin-3. Amer. J. Pathol., 148, 1661-1670 (1996).
16. IRIMURA, T., MATSUSHITA, Y., SUTTON, R.C., CARRALERO, D., OHANESSIAN, D.W., CLEARLY, K.R., OTA, D.M., NICOLSON, G.L. and LOTAN, R., Increased content of an endogenous lactose-binding lectin in human colorectal carcinoma progressed to metastatic stages. Cancer Res., 51, 387-393 (1991).
17. ITZKOWITZ, S.H., Galectins: multipurpose carbohydrate-binding proteins implicated in tumor biology. Gastroenterology, 113, 2003-2005 (1997).
18. KASAI, K. and HIRABAYASHI, J., Galectins: A family of animal lectins that decipher glycocodes. J. Biochem. (Tokyo), 119, 1-8 (1996).
19. KEW, M.C., Tumors of the liver. In D. Zakim and T.D. Boyer (eds.), Hepatology. A textbook of liver disease, pp. 1206-1240, W.B. Saunders, Philadelphia (1990).
20. KOIKE, K., SHIRAKATA, Y. and YAGINUMA, K., Oncogenic potential of hepatitis B virus. Mol. Biol. Med., 6, 151-160 (1989).
21. KONSTANTINOV, K.N., ROBBINS, B.A. and LIU, F.-T., Galectin-3, a β-galactoside-binding animal lectin, is a marker of anaplastic large-cell lymphoma. Amer. J. Pathol., 148, 25-30 (1996).
22. LIU, F.-T., Molecular biology of IgE-binding protein, IgE-binding factors and IgE receptors. CRC Crit. Rev. Immunol., 10, 289-306 (1990).
23. LIU, F.-T., HSU, D.K., ZUBERI, R.I., KUWABARA, I., CHI, E.Y. and HENDERSON, W.R., JR. Expression and function of galectin-3, a β-galactoside-binding lectin, in human monocytes and macrophages. Amer. J. Pathol., 147, 1016-1029 (1995).
24. LIU, F.-T., HSU, D.K., ZUBERI, R.I., HILL, P.N., SHENHAV, A., KUNABARA, I. and CHEN, S.S., Modulation of functional properties of galectin-3 by monoclonal antibodies binding to the non-lectin domain. Biochemistry, 35, 6073-6079 (1996).
25. LOTZ, M.M., ANDREWS, C.W., JR., KORZELIUS, C.A., LEE, E.C., STEELE, G.D., JR., CLARKE, A. and MERCURIO, A.M., Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proc. nat. Acad. Sci (Wash.), 90, 3466-3472 (1993).
26. MACNAB, G.M., ALEXANDER, J.J., LECATSAS, G., BEY, E.M. and URBANOWICZ, J.M., Hepatitis B surgace antigen produced by a human hepatoma cell line. Brit. J.Cancer, 34, 509-515 (1976).
27. MAGUIRE, H.F., HOEFFLER, J.P. and SIDDIQUI, A., HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science, 252, 842-844 (1991).
28. MCLACHLAN, A., MILICH, D.R., RANEY, A.K., RIGGS, M.G., HUGHES, J.L., SORGE, J. and CHISARI, V., Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences. J. Virol., 61, 683-692 (1987).
29. MOUTSATSOS, I.K., WADE, M., SCHINDLER, M. and WANG, J.L., Endogenous lectins from cultured cells: Nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proc. nat. Acad. Sci. (Wash.), 84, 6452-6456 (1987).
30. NAKABAYASHI, H., TAKETA, K., MIYANO, K., YAMANE, T. and SATO, J., Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res., 42, 3858-3864 (1982).
31. RAZ, A., MEROMSKY, L. and LOTAN, R., Differential expression of endogenous lectins on the surface of nontumorigenic, tumorigenic and metastatic cells. Cancer Res., 46, 3667-3672 (1986).
32. RAZ, A., ZHU, D., HOGAN, V., SHAH. N., RAZ, T., KARKASH, R., PAZERINI, G. and CARMI, P., Evidence for the role of 34-kDa galactoside-binding lectin in transformation and metastasis. Int. J. Cancer, 46, 871-877 (1990).
33. ROBINSON, W.S. The role of hepatitis B virus in development of primary hepatocellular carcinoma: Part II. J. Gastroenterol. Hepatol, 8, 95-106 (1993).
34. SANJUÁN, X., FERNÁNDEZ, P.L., CASTELLS, A., CASTRONOVO, V., VAN DEN BRULE, F., LIU, F.T., CARDESA, A., and CAMPO, E., Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology, 113, 1906-1915 (1997).
35. SETO, E.P., MITCHELL, J. and YEN, S.B., Transactivation by the hepatitis B virus X protein depends on AP-2 and other transcription factors. Nature (Lond.), 344, 72-74 (1990).
36. TWU, J.S., CHU, K. and ROBINSON, W.S., Hepatitis B virus X-gene activates kappaB-like enhancer sequences in HIV-1 LTR. Proc. at. Acad. Sci (Wash.), 86, 5168-5172 (1989).
37. VAN DEN BRÚLE, F.A., BERCHUCK, A., BAST, R.C., LIU, F.T., GILLET, C., SOBEL, M.E. and CASTRONOVO V., Differential expression of the 67-kD-laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinoma. Europ. J. Cancer, 30A, 1096-1099 (1994).
38. WU, J.-Y., XHOU, Z.Y., JUDD, A., CARTWRIGHT, C.A. and ROBINSON, W.S., The hepatitis B virus-encoded transcriptional transactivator HBX appears to be a novel serine/threonine kinase. Cell, 63, 687-695 (1990).
39. YANG, R.-Y., HSU, D.K. and LIU, F.-T., Expression of galectin-3 modulates T cell growth and apoptosis. Proc. nat. Acad. Sci. (Wash.), 93, 6737-6742 (1996).